Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentCash from Financing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Fennec Pharmaceuticals (FENC) Net Income (2016 - 2025)

Historic Net Income for Fennec Pharmaceuticals (FENC) over the last 15 years, with Q3 2025 value amounting to -$623000.0.

  • Fennec Pharmaceuticals' Net Income rose 8909.12% to -$623000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was -$6.4 million, marking a year-over-year decrease of 58835.47%. This contributed to the annual value of -$436000.0 for FY2024, which is 9728.26% up from last year.
  • As of Q3 2025, Fennec Pharmaceuticals' Net Income stood at -$623000.0, which was up 8909.12% from -$3.2 million recorded in Q2 2025.
  • In the past 5 years, Fennec Pharmaceuticals' Net Income ranged from a high of $12.9 million in Q1 2024 and a low of -$10.3 million during Q4 2022
  • For the 5-year period, Fennec Pharmaceuticals' Net Income averaged around -$3.4 million, with its median value being -$4.1 million (2021).
  • Within the past 5 years, the most significant YoY rise in Fennec Pharmaceuticals' Net Income was 31658.0% (2024), while the steepest drop was 22247.32% (2024).
  • Quarter analysis of 5 years shows Fennec Pharmaceuticals' Net Income stood at -$4.2 million in 2021, then tumbled by 145.15% to -$10.3 million in 2022, then surged by 74.66% to -$2.6 million in 2023, then surged by 42.67% to -$1.5 million in 2024, then soared by 58.49% to -$623000.0 in 2025.
  • Its Net Income stands at -$623000.0 for Q3 2025, versus -$3.2 million for Q2 2025 and -$1.2 million for Q1 2025.